Brief: Duality Biotherapeutics Inc Says Si Wen Tendered Resignation As Exec Director
23/03/2026 14:01
March 23 (Reuters) - Duality Biotherapeutics 9606.HK: SI WEN TENDERED HER RESIGNATION AS AN EXECUTIVE DIRECTOR HUA HAIQING HAS BEEN APPOINTED AS AN EXECUTIVE DIRECTOR ZHANG SHAOREN HAS BEEN APPOINTED AS CFO Further company coverage: 9606.HK ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Duality Biotherapeutics
See all newsDuality Biotherapeutics rises most in near six weeks on Roche's Genentech tie-up
Brief: Duality Biotherapeutics Says Global Research And Development Collaboration And License Agreement With Genentech
Brief: Duality Biotherapeutics Obtains Acceptance From Shanghai Securities Regulatory Bureau For Counselling On Proposed RMB Share Listing
Brief: Duality Biotherapeutics Announces Share Repurchase Plan Of Up To $40 Million
Brief: Duality Biotherapeutics Approved Proposed RMB Share Issue On Sci-Tech Board